Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA clearance for ChloraDerm antimicrobial film dressing

Jan. 27, 2016

CE Mark for Quidel's Sofia S. pneumoniae Fluorescent Immunoassay

Jan. 27, 2016

Pharmaceutical industry calls for government collaboration to fight antibiotic resistance

Jan. 26, 2016

Worldwide collaborations to control recent Zika virus outbreaks / News in Context

Jan. 26, 2016

Takeda's H. influenzae type b conjugate vaccine approved in Japan

Jan. 25, 2016

Gavi and Merck & Co. sign agreement in support of Ebola Zaire vaccine

Jan. 22, 2016

Hetero Research Foundation presents antiviral agents

Jan. 22, 2016

Bispecific antibodies neutralize both Zaire and Sudan Ebola virus strains

Jan. 22, 2016

Daiichi Sankyo develops LRS inhibitors

Jan. 21, 2016

Spero Therapeutics describes antibacterials

Jan. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...